Cutting Edge: A New Player in the Alternative Complement Pathway, MASP-1 Is Essential for LPS-Induced, but Not for Zymosan-Induced, Alternative Pathway Activation.
J Immunol
; 200(7): 2247-2252, 2018 04 01.
Article
in En
| MEDLINE
| ID: mdl-29475986
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Zymosan
/
Lipopolysaccharides
/
Complement Pathway, Alternative
/
Complement Pathway, Mannose-Binding Lectin
/
Mannose-Binding Protein-Associated Serine Proteases
Limits:
Humans
Language:
En
Journal:
J Immunol
Year:
2018
Document type:
Article
Country of publication:
United States